Hanmi Science Co., Ltd.
KSE 008930.KS
Hanmi Science Co., Ltd. Total Non-Current Liabilities for the year ending December 31, 2023: USD 33.40 M
Hanmi Science Co., Ltd. Total Non-Current Liabilities is USD 33.40 M for the year ending December 31, 2023, a 13.62% change year over year. Total non-current liabilities are the sum of long-term debt and other non-current liabilities.
-
Hanmi Science Co., Ltd. Total Non-Current Liabilities for the year ending December 31, 2022 was USD 29.40 M, a -9.01% change year over year.
-
Hanmi Science Co., Ltd. Total Non-Current Liabilities for the year ending December 31, 2021 was USD 32.31 M, a -20.68% change year over year.
-
Hanmi Science Co., Ltd. Total Non-Current Liabilities for the year ending December 31, 2020 was USD 40.73 M, a 27.87% change year over year.
-
Hanmi Science Co., Ltd. Total Non-Current Liabilities for the year ending December 31, 2019 was USD 31.86 M, a -1.64% change year over year.
Key data
| Date | Total Non-Current Liabilities | Shareholders' Equity | Other Liabilities | Total Liabilities |
|---|
Market news
Loading...
Don’t Miss A Beat
KSE: 008930.KS
| CEO | Mr. Jong-Hoon Lim |
| IPO Date | Sept. 29, 2005 |
| Location | South Korea |
| Headquarters | 14, Wiryeseong-daero |
| Employees | 402 |
| Sector | Healthcare |
| Industries | |
Description
Hanmi Science Co., Ltd., through its subsidiaries, manufactures and sells pharmaceutical products in Korea and internationally. It develops drugs in the areas of diabetes and anti-cancer. The company also offers drug substances, general medicines, health functional foods, and nutrition and health products and services. In addition, it operates an online pharmacy; and offers pharmaceutical management automation systems. The company was formerly known as Hanmi Holdings Co., Ltd. and changed its name to Hanmi Science Co., Ltd. in March 2012. Hanmi Science Co., Ltd. was founded in 1973 and is based in Seoul, South Korea.
Key trends
Past 5 years
StockViz Staff
February 4, 2025
Any question? Send us an email